Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Cash Flows From Operating Activities:
Net loss	$ (9,574,987)	$ (17,291,732)
Adjustments to reconcile net loss to cash used in operating activities
Change in fair value of warrant liability	(24,370)	(94,396)
Change in fair value of investment option liability	(21,620)	(208,752)
Change in fair value of derivative liability		(727,000)
Stock-based compensation	1,562,392	2,150,160
Inducement expense		1,848,235
Deferred offering costs expensed	418,200
Amortization of right of use asset		64,048
Amortization of intangibles	168,750	168,754
Depreciation expense	168,739	175,228
Gain on disposal of property and equipment		(4,206)
Change in operating assets and liabilities:
Prepaid expenses and other current assets	178,496	(6,857)
Accounts payable and accrued liabilities	(834,630)	(103,848)
Due to related parties	232,891
Right-of-use operating lease asset and obligation		(64,045)
Net cash used in operating activities	(7,726,139)	(14,094,411)
Cash Flows From Investing Activities:
Purchases of property and equipment		(5,180)
Proceeds from disposal of property and equipment		16,847
Net cash provided by investing activities		11,667
Cash Flows From Financing Activities:
Proceeds from the subscription receivable related to the issuance of Inducement Warrants and the exercise of warrants and preferred investment options	1,804,819
Proceeds from exercise of Inducement Warrants	2,676,980
Proceeds from common stock sold under the Equity Distribution Agreement, net of offering costs	2,290,186
Proceeds from common stock sold under the Purchase Agreement, net of offering costs	1,083,706
Payment for offering costs previously accrued	(181,857)
Payment for equity distribution offering costs		(291,084)
Redemption of Series A Preferred Stock		(1,052,057)
Net cash provided by (used in) financing activities	7,673,834	(1,343,141)
Effect of foreign exchange rate on changes on cash	5,354	(10,022)
Net decrease in cash	(46,951)	(15,435,907)
Cash at beginning of year	2,287,977	17,723,884
Cash at end of year	2,241,026	2,287,977
Supplemental disclosure of cash flow transactions:
Cash paid for interest
Income taxes paid	5,000	9,507
Non-cash financing and investing activities:
Stock subscription receivable		1,817,640
Offering costs accrued not paid		182,724
Warrants issued for offering costs		77,991
Issuance of common shares for offering costs	771,293	255,107
Deferred offering costs charged to offering costs	612,000
Induced conversion of warrants and preferred investment options		683,997
Preferred dividends attributable to redeemable non-controlling interest		19,041
Accretion of embedded derivative to redemption value		$ 147,988